Negative regulation of constitutive NF-κB and JNK signaling by PKN1-mediated phosphorylation of TRAF1

Genes to Cells

Volumn 13, Issue 5, 2008, Pages 509-520

  Kato Jr , Tomohisa ^a,c   Gotoh, Yusuke ^a   Hoffmann, Alexander ^b   Ono, Yoshitaka ^a  

^a KOBE UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ARTICLE; ATTENUATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOICHIOMETRY;

CELL LINE; GENE SILENCING; HELA CELLS; HUMANS; I-KAPPA B KINASE; MAP KINASE KINASE 4; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1;

EID: 42449091958     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2008.01182.x     Document Type: Article

References (48)

1. Antonyak, M.A., Kenyon, L.C., Godwin, A.K., James, D.C., Emlet, D.R., Okamoto, I., Tnani, M., Holgado-Madruga, M., Moscatello, D.K. & Wong, A.J. (2002) Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene 21, 5038-5046.
2. Arch, R.H., Gedrich, R.W. & Thompson, C.B. (1998) Tumor necrosis factor receptor-associated factors (TRAFs)-family of adapter proteins that regulates life and death. Genes Dev. 12, 2821-2830.
3. Ashkenazi, A. & Dixit, V.M. (1998) Death receptors: Signaling and modulation. Science 281, 1305-1308.
4. Bacher, S. & Schmitz, M.L. (2004) The NF-κB pathway as a potential target for autoimmune disease therapy. Curr. Pharm. Des. 10, 2827-2837.
5. Bouwmeester, T., Bauch, A., Ruffner, H., et al. (2004) A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nat. Cell Biol. 6, 97-105.
6. Bradley, J.R. & Pober, J.S. (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20, 6482-6491.
7. Chaudhuri, A., Orme, S., Vo, T., Wang, W. & Cherayil, B.J. (1999) Phosphorylation of TRAF2 inhibits binding to the CD40 cytoplasmic domain. Biochem. Biophys. Res. Commun. 256, 620-625.
8. Chen, Z.J. (2005) Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol. 7, 758-765.
9. Courtois, G. & Gilmore, T.D. (2006) Mutations in the NF-κB signaling pathway: Implications for human disease. Oncogene 25, 6831-6843.
10. Davis, R.J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
11. Derijard, B., Hibi, M., Wu, I.H., Barrett, T., Su, B., Deng, T., Karin, M. & Davis, R.J. (1994) JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037.
12. Dunne, A. & O'Neill, L.A. (2003) The interleukin-1 receptor/ Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci. STKE 171, RE3.
13. Fotin-Mleczek, M., Henkler, F., Hausser, A., Glauner, H., Samel, D., Graness, A., Scheurich, P., Mauri, D. & Wajant, H. (2004) Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-κB activation. J. Biol. Chem. 279, 677-685.
14. Gerondakis, S., Grumont, R., Gugasyan, R., Wong, L., Isomura, I., Ho, W. & Banerjee, A. (2006) Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models. Oncogene 25, 6781-6799.
15. Ghosh, S. & Karin, M. (2002) Missing pieces in the NF-κB puzzle. Cell 109 (Suppl.), S81-S96.
16. Gotoh, Y., Oishi, K., Shibata, H., Yamagiwa, A., Isagawa, T., Nishimura, T., Goyama, E., Takahashi, M., Mukai, H. & Ono, Y. (2004) Protein kinase PKN1 associates with TRAF2 and is involved in TRAF2-NF-κB signaling pathway. Biochem. Biophys. Res. Commun. 314, 688-694.
17. Haraga, A. & Miller, S.I. (2006) A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell Microbiol. 8, 837-846.
18. Hayden, M.S. & Ghosh, S. (2004) Signaling to NF-κB. Genes Dev. 18, 2195-2224.
19. Hibi, M., Lin, A., Smeal, T., Minden, A. & Karin, M. (1993) Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7, 2135-2148.
20. Hoffmann, A., Levchenko, A., Scott, M.L. & Baltimore, D. (2002) The NF-κB signaling module: Temporal control and selective gene activation. Science 298, 1241-1245.
21. Inoue, J., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S. & Yamamoto, T. (2000) Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254, 14-24.
22. Isagawa, T., Takahashi, M., Kato, T. Jr, Mukai, H. & Ono, Y. (2005) Involvement of protein kinase PKN1 in G2/M delay caused by arsenite. Mol. Carcinog. 43, 1-12.
23. Jiang, Y., Woronicz, J.D., Liu, W. & Goeddel, D.V. (1999) Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283, 543-546.
24. Karin, M. (2006) Nuclear factor-κB in cancer development and progression. Nature 441, 431-436.
25. Karin, M. & Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 18, 621-663.
26. Karin, M. & Gallagher, E. (2005) From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57, 283-295.
27. Kato, T. Jr, Delhase, M., Hoffmann, A. & Karin, M. (2003) CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB activation during the UV response. Mol. Cell 12, 829-839.
28. Kyriakis, J.M. & Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869.
29. Li, Q. & Verma, I.M. (2002) NF-κB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
30. Liu, J., Yang, D., Minemoto, Y., Leitges, M., Rosner, M.R. & Lin, A. (2006) NF-κB is required for UV-induced JNK activation via induction of PKCd. Mol. Cell 21, 467-480.
31. Locksley, R.M., Killeen, N. & Lenardo, M.J. (2001) The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104, 487-501.
32. Lu, T. & Stark, G.R. (2004) Cytokine overexpression and constitutive NF-κB in cancer. Cell Cycle 3, 1114-1117.
33. Manning, A.M. & Davis, R.J. (2003) Targeting JNK for therapeutic benefit: From junk to gold? Nat. Rev. Drug Discov. 2, 554-565.
34. Mukai, H. (2003) The structure and function of PKN, a protein kinase having a catalytic domain homologous to that of PKC. J. Biochem. (Tokyo) 133, 17-27.
35. Mukai, H. & Ono, Y. (1994) A novel protein kinase with leucine zipper-like sequences: Its catalytic domain is highly homologous to that of protein kinase C. Biochem. Biophys. Res. Commun. 199, 897-904.
36. Rothe, M., Wong, S.C., Henzel, W.J. & Goeddel, D.V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
37. Rothwarf, D.M. & Karin, M. (1999) The NF-κB activation pathway: A paradigm in information transfer from membrane to nucleus. Sci. STKE 5, RE1.
38. Sabapathy, K., Hochedlinger, K., Nam, S.Y., Bauer, A., Karin, M. & Wagner, E.F. (2004) Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol. Cell 15, 713-725.
39. Sun, L. & Chen, Z.J. (2004) The novel functions of ubiquitination in signaling. Curr. Opin. Cell Biol. 16, 119-126.
40. Takahashi, M., Mukai, H., Toshimori, M., Miyamoto, M. & Ono, Y. (1998) Proteolytic activation of PKN by caspase-3 or related protease during apoptosis. Proc. Natl. Acad. Sci. USA 95, 11566-11571.
41. Tournier, C., Hess, P., Yang, D.D., Xu, J., Turner, T.K., Nimnual, A., Bar-Sagi, D., Jones, S.N., Flavell, R.A. & Davis, R.J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-874.
42. Tsitsikov, E.N., Laouini, D., Dunn, I.F., Sannikova, T.Y., Davidson, L., Alt, F.W. & Geha, R.S. (2001) TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice. Immunity 15, 647-657.
43. Ventura, J.J., Hubner, A., Zhang, C., Flavell, R.A., Shokat, K.M. & Davis, R.J. (2006) Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell 21, 701-710.
44. Ventura, J.J., Kennedy, N.J., Flavell, R.A. & Davis, R.J. (2004) JNK regulates autocrine expression of TGF-β1. Mol. Cell 15, 269-278.
45. Wajant, H., Henkler, F. & Scheurich, P. (2001) The TNF-receptor-associated factor family: Scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal. 13, 389-400.
46. Wallach, D., Varfolomeev, E.E., Malinin, N.L., Goltsev, Y.V., Kovalenko, A.V. & Boldin, M.P. (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331-367.
47. Werner, S.L., Barken, D. & Hoffmann, A. (2005) Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309, 1857-1861.
48. Xu, L.G., Li, L.Y. & Shu, H.B. (2004) TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. J. Biol. Chem. 279, 17278-17282.